上海肽仕生物科技有限公司是一家以技術為基礎，專注於多肽開發的生物公司，主要從事於客戶肽定製合成與藥物活性多肽的研發和生產。肽仕向全世界的生命科學研究和製藥工業提供全面的多肽服務。作為一家以客戶為中心，以成為“多肽領域的卓越領導者”為願景的公司，我們通過高效率，高性價比的產品和服務幫助全球客戶在其項目開發與產品生產過程中縮短周期，降低成本。
基本介紹
- 中文名：上海肽仕生物科技有限公司
- 專業方向：生物
- 主要業務：客戶肽定製合成與藥物活性多肽
- 類型：公司
中文簡介,英文簡介,
中文簡介
上海肽仕生物科技有限公司高性價比多肽品牌；肽仕提供標準化、經濟實惠的多肽產品，以及獨樹一幟的肽庫標準品。目前，我們高效率地客服體系讓您在多肽項目計畫中得到更多有效的幫助。
上海肽仕生物科技有限公司品質多肽個性化服務；肽仕為全球生命科學家、研究人員和製藥公司設立獨特的多肽生產線以及特殊的修飾服務，我們將在短時間內為您提供創新的多肽技術解決方案以及更多高品質的多肽產品。
上海肽仕生物科技有限公司利用實驗室共享和技術優勢成功的將常用藥物多肽中間體公斤級產業化了六十幾個品種，為全球科研工作人員提供的活性多肽套用選擇超過了2300多種，並陸續開發出了多肽末端、位點、主鏈變構等多種複雜的修飾。肽仕以人才為創新資產，我們的服務與創新質量已得到世界科研者的廣泛認可。為實現更多肽類化合物產業化的成熟，肽仕將持續投入並創新更多有關多肽生命科學發展。
英文簡介
Shanghai TASH Biotechnology Co.,Ltd. specializes in peptide development on the basis of high technology. We are focusing on custom peptide synthesis, and the research, development and manufacturing of biologically active peptides for drugs. We provide comprehensive services on peptide to the life science research institutes and pharmaceutical industry worldwide. Our principle is “customers first”, and our goal is to be a prominent leader in peptide industry. Our high cost performance products and high-effective services allows for accelerated schedules to be met and a cost-effective manner to be adopted for our customers on their product development and manufacturing.
A high cost performance peptides provider: TASH supplies not only economic standardized peptide products, but also unparalleled peptide library standards. Our high-effective customer service system makes more support and assistance available for your peptide project.
High-quality peptides and specific services: TASH has started up specific peptide product line for the life scientists, researchers and pharmaceutical companies worldwide, and also provides unique peptide modification services. Innovative peptide technical solutions and more high-quality peptide products can be obtained in a quicker manner.
Up to the present, we have successfully realized the industrialization of peptide intermediates and ingredients for generic drugs at kilogram basis into more than sixty varieties, leveraging lab resource sharing and technical advantages. And the biologically active peptide choices we offer for the scientific researchers throughout the whole world have exceeded 2,300. We have also developed in succession multiple peptide modifications including the ones of peptide terminals, loci, and main chain allostery. TASH relies on qualified personnel for innovation. Our services and innovation achievements have been recognized by the scientific researchers worldwide. In order to realize the perfect industrialization of more peptide compounds, we would continue to invest in peptide industry and encourage innovation peptide life science.
